Country: Ástralía
Tungumál: enska
Heimild: Department of Health (Therapeutic Goods Administration)
benzatropine mesilate, Quantity: 1 mg/mL
Phebra Pty Ltd
benzatropine mesilate
Injection
Excipient Ingredients: sodium chloride; water for injections
Intramuscular, Intravenous
10 & 5
(S4) Prescription Only Medicine
Benzatropine Injection is recommended for all forms of parkinsonism - including arteriosclerotic, post-encephalitic, idiopathic, as well as drug induced extrapyramidal disorders (except tardive dyskinesia). It can be effective at any stage of the disease, even when a patient has become bedridden. Benzatropine Injection often is helpful in patients who have become unresponsive to other agents. Benzatropine Injection is a powerful antichlolinergic agent which is mainly effective in relieving tremor and rigidity. Therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. In non-drug-induced parkinsonism, partial control of symptoms is usually achieved.
Visual Identification: A clear particle free solution; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-07-18
Benzatropine Injection 1 of 3 Version 0_2_ BENZATROPINE INJECTION Contains benzatropine mesilate 2 mg in 2 mL BENZ-troe-peen Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about Benzatropine Injection. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits. Your doctor has weighed the risks of you being given Benzatropine Injection against the benefits they expect it will have for you. If you have any concerns about being given this medicine, ask your doctor. Keep this leaflet in a safe place. You may need to read it again. What Benzatropine Injection is used for Benzatropine Injection is used to treat some of the symptoms of parkinsonism. The symptoms of parkinsonism include slow and unsteady movement, muscle stiffness and shaking (tremors). If untreated, parkinsonism can cause difficulty in performing normal daily activities. Symptoms of parkinsonism can be caused by certain diseases of the brain affecting movement, such as Parkinson’s disease. They can also be caused by some medicines that are used to treat certain mental conditions. Benzatropine Injection is most helpful in improving muscle stiffness and shaking. Benzatropine Injection belongs to a group of medicines called anticholinergics. It comes as an injection. Benzatropine Injection works by blocking the effects of acetylcholine, a naturally occurring chemical produced by brain cells that can interfere with the regions of the brain that control muscle movement. In many patients, this reduces the symptoms of shaking and muscle stiffness. Ask your doctor if you have any questions about why this medicine has been prescribed for you. Your doctor may have prescribed it for another reason. This medicine is available only with a doctor’s prescription. Before you are given Benzatropine Injection When you must not be given it You should not be given Benzatropine Injection if you have an allergy to: any medicine contai Lestu allt skjalið
PRODUCT INFORMATION Australian Product Information – Benzatropine Injection Page 1 of 8 Version 03 BENZATROPINE INJECTION (BENZATROPINE MESILATE) 1 NAME OF THE MEDICINE Benzatropine mesilate 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Benzatropine Injection is available as 2 mg in 2 mL vials. Benzatropine Injection contains benzatropine mesilate as the active ingredient. For the full list of excipients, see Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM Benzatropine Injection, 2 mg in 2 mL, clear, colourless, particle free solution. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Benzatropine Injection is recommended for all forms of parkinsonism - including arteriosclerotic, post-encephalitic, idiopathic, as well as drug-induced extrapyramidal disorders (except tardive dyskinesia). It can be effective at any stage of the disease, even when a patient has become bedridden. Benzatropine Injection often is helpful in patients who have become unresponsive to other agents. Benzatropine Injection is a powerful anticholinergic agent which is mainly effective in relieving tremor and rigidity. Therapy is directed toward control of disturbing symptoms to permit the patient maximum integration of function with minimum discomfort. In non-drug-induced parkinsonism, partial control of symptoms is usually achieved. 4.2 D OSE AND METHOD OF ADMINISTRATION Benzatropine Injection is available as an injection for intravenous and intramuscular use. Each millilitre of the injection contains: Benzatropine mesilate 1.0 mg Sodium chloride 9.0 mg Water for injections q.s 1.0 mL Because Benzatropine Injection is cumulative in action, therapy should be initiated with a small dose which then can be increased gradually at five- or six-day intervals. Increases in dosage should be made in increments of 0.5 mg, to a maximum of 6 mg. PRODUCT INFORMATION BENZATROPINE INJECTION Australian Product Information – Benzatropine Injection Page 2 of 8 Version 03 The injection is especially useful for psychotic patients with acute dystonic re Lestu allt skjalið